Leggett and Platt, Incorporated (LEG)

On our desk, the recent Q2 2026 prints show top-line weakness with sales dropping to $999.7 million and lower net income. While adjusted non-GAAP figures showed some resilience with EBIT moving up to $89.0 million, the broader market narrative remains defensive given soft housing and bedding conditions.

Looking at the risk factors from a quantitative standpoint, the net debt to trailing 12-month adjusted EBITDA ratio sits at 2.57x based on $370.9 million of adjusted EBITDA. Operating cash flows dropped significantly to $45.8 million in the quarter compared to $84.0 million previously, highlighting meaningful cash generation pressures.

Our market panel remains bearish on LEG due to the severe lack of transparency surrounding Somnigroup's financial health, margins, and debt load. Diluting legacy control down to a small minority stake via an all-stock structure transfers unquantified risks straight to current shareholders.

From an MandA arbitration perspective, LEG shareholders voted to adopt the Somnigroup merger agreement with over 102 million votes in favor. However, the transaction's fate now critically depends on five foreign regulators and the volatile SGI share price, creating substantial execution uncertainty.

Operational strain is clearly visible in the latest August 2026 filings, which highlight pending merger litigation, manufacturing footprint optimization, and significant exposure to trade regulations and tariffs affecting vertically integrated steel rod and wire operations.